Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Anne Phillips

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Familial Cancer|December 4, 2012
Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancerBettina Meiser, Melanie A Price, Phyllis N Butow, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Prostate screening uptake in Australian BRCA1 and BRCA2 carriersJoanne M McKinley, Prue C Weideman, Mark A Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family RegistryKelly-Anne Phillips, Roger L Milne, Saundra Buys, et al.
Breast Cancer Research : BCR|February 7, 2006
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutationGillian Mitchell, Yoland C Antill, William Murray, et al.
Psycho-Oncology|April 21, 2018
Does stress increase risk of breast cancer? A 15-year prospective studyPhyllis Butow, Melanie Price, Joseph Coll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerIan M Collins, Roger L Milne, Sue Anne McLachlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriersYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Breast Cancer Research and Treatment|August 12, 2009
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)Belinda E Kiely, Mark A Jenkins, Joanne M McKinley, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Journal of the National Cancer Institute|May 28, 2021
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic EvaluationWanyuan Cui, Prudence A Francis, Sherene Loi, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Familial Cancer|December 4, 2012
Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancerBettina Meiser, Melanie A Price, Phyllis N Butow, et al.
Hereditary Cancer in Clinical Practice|September 4, 2009
Prostate screening uptake in Australian BRCA1 and BRCA2 carriersJoanne M McKinley, Prue C Weideman, Mark A Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family RegistryKelly-Anne Phillips, Roger L Milne, Saundra Buys, et al.
Breast Cancer Research : BCR|February 7, 2006
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutationGillian Mitchell, Yoland C Antill, William Murray, et al.
Psycho-Oncology|April 21, 2018
Does stress increase risk of breast cancer? A 15-year prospective studyPhyllis Butow, Melanie Price, Joseph Coll, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerIan M Collins, Roger L Milne, Sue Anne McLachlan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriersYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Breast Cancer Research and Treatment|August 12, 2009
Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)Belinda E Kiely, Mark A Jenkins, Joanne M McKinley, et al.
Familial Cancer|July 4, 2006
Screening behavior in women at increased familial risk for breast cancerYoland C Antill, John Reynolds, Mary Anne Young, et al.
Journal of the National Cancer Institute|May 28, 2021
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic EvaluationWanyuan Cui, Prudence A Francis, Sherene Loi, et al.
Pageof 16